Management of Recurrent Respiratory Papillomatosis: Current Status
KK Handa, TB Shashidhar
Citation Information :
Handa K, Shashidhar T. Management of Recurrent Respiratory Papillomatosis: Current Status. Int J Phonosurg Laryngol 2011; 1 (1):33-36.
Recurrent respiratory papillomatosis is benign disorder which affects children and requires long-term multiple surgical extirpations. The authors present their experience of different techniques in 35 patients and the literature is reviewed.
The quality of life and health utility burden of recurrent respiratory papillomatosis in children. Otolaryngol Head-Neck Surg Nov 2010;143(5):685-90.
Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head-Neck Surg 1995;121:1386.
Recurrent respiratory papillomatosis: A review. Laryngoscope. Jul 2008;118(7):1236-47.
Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One. May 2008;28;3(5):e2263.
Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101:645-52.
Ann Otol Rhinol Laryngol 2006;115:679.
Otolaryngol Head-Neck Surg 2006;134:1023.
Powered instrumentation in the treatment of recurrent respiratory papillomatosis: An alternative to the carbon dioxide laser. Arch Otolaryngol Head-Neck Surg 2002;128:425-28.
Arch Otolaryngol Head-Neck Surg 2004;130:1039.
British Association of Paediatric Otolaryngology members experience with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2006; 20:1183-87.
Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head-Neck Surg 1999;125:1143-48.
Multi-Disciplinary Task Force on Recurrent Respiratory Papillomas. Cidofovir for recurrent respiratory papillomatosis (RRP): A reassessment of risks. Int J Pediatr Otorhinolaryngol 2005;69:1465-67.
Soma and David M. Albert. Cidofovir: To use or not to use? Current Opinion in Otolaryngology & Head and Neck Surgery 2008;16:86-90.
Quadrivalent human papillomavirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2007;56:1-24.
